vs
Side-by-side financial comparison of Cinemark Holdings, Inc. (CNK) and ResMed (RMD). Click either name above to swap in a different company.
ResMed is the larger business by last-quarter revenue ($1.4B vs $776.3M, roughly 1.8× Cinemark Holdings, Inc.). ResMed runs the higher net margin — 27.6% vs 4.4%, a 23.2% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs -4.7%). Over the past eight quarters, Cinemark Holdings, Inc.'s revenue compounded faster (15.8% CAGR vs 7.9%).
Cinemark Holdings, Inc. is an American movie theater chain that started operations in 1977 and since then has operated theaters with hundreds of locations throughout the Americas. It is headquartered in Plano, Texas, in the Dallas–Fort Worth area. Cinemark operates 497 theaters and 5,653 screens in the U.S. and Latin America as of March 2025. It is also the largest movie theater chain in Brazil, with a 30 percent market share.
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
CNK vs RMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $776.3M | $1.4B |
| Net Profit | $34.1M | $392.6M |
| Gross Margin | — | 61.8% |
| Operating Margin | — | 34.6% |
| Net Margin | 4.4% | 27.6% |
| Revenue YoY | -4.7% | 11.0% |
| Net Profit YoY | -33.5% | 13.9% |
| EPS (diluted) | $0.33 | $2.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $1.4B | ||
| Q4 25 | $776.3M | $1.4B | ||
| Q3 25 | $857.5M | $1.3B | ||
| Q2 25 | $940.5M | $1.3B | ||
| Q1 25 | $540.7M | $1.3B | ||
| Q4 24 | $814.3M | $1.3B | ||
| Q3 24 | $921.8M | $1.2B | ||
| Q2 24 | $734.2M | $1.2B |
| Q2 26 | — | $392.6M | ||
| Q4 25 | $34.1M | $392.6M | ||
| Q3 25 | $49.5M | $348.5M | ||
| Q2 25 | $93.5M | $379.7M | ||
| Q1 25 | $-38.9M | $365.0M | ||
| Q4 24 | $51.3M | $344.6M | ||
| Q3 24 | $187.8M | $311.4M | ||
| Q2 24 | $45.8M | $292.2M |
| Q2 26 | — | 61.8% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% |
| Q2 26 | — | 34.6% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% |
| Q2 26 | — | 27.6% | ||
| Q4 25 | 4.4% | 27.6% | ||
| Q3 25 | 5.8% | 26.1% | ||
| Q2 25 | 9.9% | 28.2% | ||
| Q1 25 | -7.2% | 28.3% | ||
| Q4 24 | 6.3% | 26.9% | ||
| Q3 24 | 20.4% | 25.4% | ||
| Q2 24 | 6.2% | 23.9% |
| Q2 26 | — | $2.68 | ||
| Q4 25 | $0.33 | $2.68 | ||
| Q3 25 | $0.40 | $2.37 | ||
| Q2 25 | $0.63 | $2.58 | ||
| Q1 25 | $-0.32 | $2.48 | ||
| Q4 24 | $0.36 | $2.34 | ||
| Q3 24 | $1.19 | $2.11 | ||
| Q2 24 | $0.32 | $1.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $663.8M |
| Stockholders' EquityBook value | — | $6.3B |
| Total Assets | — | $8.5B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M |
| Q2 26 | — | $663.8M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
| Q2 26 | — | $6.3B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $4.9B |
| Q2 26 | — | $8.5B | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | — | $8.3B | ||
| Q2 25 | — | $8.2B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $6.9B |
| Q2 26 | — | 0.11× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNK
| Admissions Revenue | $383.8M | 49% |
| Concessions | $302.4M | 39% |
| Other Revenue | $37.5M | 5% |
| Transferred Over Time | $28.2M | 4% |
| Screen Advertising Screen Rental And Promotional Revenues | $24.4M | 3% |
RMD
Segment breakdown not available.
